Sander Yermakov

Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis

Sander Yermakov, Matthew Davis, Michaela Calnan et al. · Journal of Medical Economics · 2015 · 57 citations · Full text

Pharmacy, Pharmacoeconomics, Health Services Research +16

Indirect comparisons of efficacy and weekly factor consumption during continuous prophylaxis with recombinant factor <scp>VIII</scp> Fc fusion protein and conventional recombinant factor <scp>VIII</scp> products

Alfonso Iorio, Sangeeta Krishnan, Karl-Johan Myrén et al. · Haemophilia · 2017 · 31 citations

Medicine, Hematology, Pharmacotherapy +14

Economic burden of brain metastases among patients with metastatic melanoma in a USA managed care population

Francis Vekeman, Michel Cloutier, Sander Yermakov et al. · Melanoma Research · 2014 · 14 citations

Medicine, Oncology, Pharmacoeconomics +17

Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS)

Lynn Huynh, Sander Yermakov, Matthew Davis et al. · Journal of Medical Economics · 2015 · 10 citations

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16